je.st
news
Patheon Expands Early Development Offerings and Capacity At U.K. Facility
2014-01-16 17:36:30| drugdiscoveryonline News Articles
Patheon's investment in early development capabilities in Europe means expanded capacity for handling highly potent compounds in the early pharmaceutical development phases at the Milton Park facility and then feeding into the later stage and commercialization capabilities at a site in Bourgoin, France.
Tags: development
uk
early
capacity
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||